PRELUENT Trademark

Trademark Overview

On Friday, April 28, 2006, a trademark application was filed for PRELUENT with the United States Patent and Trademark Office. The USPTO has given the PRELUENT trademark a serial number of 79025401. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Friday, April 29, 2016. This trademark is owned by sanofi-aventis. The PRELUENT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation for the treatment or prevention of cardiovascular diseases, and anti-thrombotic pharmaceuticals
preluent

General Information

Serial Number79025401
Word MarkPRELUENT
Filing DateFriday, April 28, 2006
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateFriday, April 29, 2016
Registration Number3294237
Registration DateTuesday, September 18, 2007
Mark Drawing5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 3, 2007

Trademark Statements

Goods and ServicesPharmaceutical preparation for the treatment or prevention of cardiovascular diseases, and anti-thrombotic pharmaceuticals

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, April 25, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSANOFI
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressFR
Party Namesanofi-aventis
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressFR
Party Namesanofi-aventis
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressFR

Trademark Events

Event DateEvent Description
Friday, November 11, 2016NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Friday, November 11, 2016DEATH OF INTERNATIONAL REGISTRATION
Friday, June 12, 2015TOTAL INVALIDATION PROCESSED BY THE IB
Thursday, April 30, 2015GENERIC MADRID TRANSACTION SENT TO IB
Thursday, April 30, 2015GENERIC MADRID TRANSACTION CREATED
Thursday, December 25, 2014TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Friday, April 25, 2014CANCELLED SECTION 71
Saturday, July 21, 2012CHANGE OF NAME/ADDRESS REC'D FROM IB
Saturday, December 10, 2011CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, September 19, 2008FINAL DECISION TRANSACTION PROCESSED BY IB
Wednesday, January 9, 2008FINAL DISPOSITION NOTICE SENT TO IB
Wednesday, January 9, 2008FINAL DISPOSITION PROCESSED
Tuesday, December 18, 2007FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, September 18, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, July 3, 2007PUBLISHED FOR OPPOSITION
Wednesday, June 13, 2007NOTICE OF PUBLICATION
Thursday, April 26, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, April 24, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, April 19, 2007AMENDMENT FROM APPLICANT ENTERED
Thursday, April 19, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, April 19, 2007APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, April 16, 2007ASSIGNED TO LIE
Monday, March 12, 2007PAPER RECEIVED
Thursday, March 8, 2007PAPER RECEIVED
Friday, October 13, 2006REFUSAL PROCESSED BY IB
Wednesday, September 27, 2006NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, September 27, 2006REFUSAL PROCESSED BY MPU
Tuesday, September 26, 2006NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Monday, September 25, 2006NON-FINAL ACTION WRITTEN
Thursday, September 21, 2006ASSIGNED TO EXAMINER
Thursday, August 3, 2006NEW APPLICATION ENTERED IN TRAM
Thursday, August 3, 2006SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

preluent anti thrombotic pharmaceuticals diseases cardiovascular preparation treatment prevention pharmaceutical